Stock DHI DR HORTON
Add to a list
To use this feature you must be a member
Log inSign up

DR Horton Stock

Equities

DHI

US23331A1097

Homebuilding

Market Closed - Nyse
Other stock markets
 04:00:02 2025-01-17 pm EST 		5-day change 1st Jan Change
147.65 USD +0.72% Intraday chart for DR Horton +6.68% +5.60%
Jan. 17 D.R. Horton's Fiscal Q1 EPS Likely to Miss Consensus Amid Rising Costs, Wedbush Says MT
Jan. 16 Barclays Adjusts D.R. Horton Price Target to $150 From $170, Maintains Equal Weight Rating MT

Valuation: DR Horton

Capitalization 47.37B 45.55B 43B 38.51B 67.83B 4,084B 75.65B 522B 194B 1,685B 178B 174B 7,374B P/E ratio 2025 *
10.6x
P/E ratio 2026 * 9.4x
Enterprise value 48.79B 46.91B 44.29B 39.66B 69.86B 4,206B 77.91B 538B 199B 1,735B 183B 179B 7,595B EV / Sales 2025 *
1.32x
EV / Sales 2026 * 1.23x
Free-Float
72.05%
Yield 2025 *
1.04%
Yield 2026 * 1.11%
More valuation ratios * Estimated data

Chart: DR Horton

Dynamic Chart

Latest news: DR Horton

D.R. Horton's Fiscal Q1 EPS Likely to Miss Consensus Amid Rising Costs, Wedbush Says Jan. 17 MT
Barclays Adjusts D.R. Horton Price Target to $150 From $170, Maintains Equal Weight Rating Jan. 16 MT
Goldman Sachs Adjusts D.R. Horton Price Target to $171 From $200, Maintains Buy Rating Jan. 14 MT
RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating Jan. 10 MT
UBS Adjusts Price Target on D.R. Horton to $203 From $214, Maintains Buy Rating Jan. 08 MT
Wells Fargo Cuts Price Target on D.R. Horton to $175 From $190, Maintains Overweight Rating Dec. 17 MT
Certain Homebuilders' Gross Margins Seen Under Pressure Heading Into 2025, BofA Says Dec. 16 MT
BofA Securities Cuts Price Target on D.R. Horton to $170 From $190, Maintains Buy Rating Dec. 16 MT
Evercore ISI Adjusts Price Target on D.R. Horton to $212 From $204 Dec. 16 MT
Argus Adjusts Price Target on D.R. Horton to $190 From $200 Dec. 16 MT
US stocks close flat ahead of next week's Fed meeting Dec. 13 RE
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading Dec. 13 MT
Sector Update: Consumer Dec. 13 MT
More news

Last Transcript: DR Horton

Logo DR Horton
D.R. Horton, Inc., Q4 2024 Earnings Call, Oct 29, 2024
24-10-29
More transcripts

Analysts' recommendations: DR Horton

Barclays Adjusts D.R. Horton Price Target to $150 From $170, Maintains Equal Weight Rating Jan. 16 MT
Goldman Sachs Adjusts D.R. Horton Price Target to $171 From $200, Maintains Buy Rating Jan. 14 MT
RBC Cuts Price Target on D.R. Horton to $125 From $145, Keeps Underperform Rating Jan. 10 MT
UBS Adjusts Price Target on D.R. Horton to $203 From $214, Maintains Buy Rating Jan. 08 MT
Wells Fargo Cuts Price Target on D.R. Horton to $175 From $190, Maintains Overweight Rating Dec. 17 MT
More recommendations

Press Releases: DR Horton

Kroger Acquires Land in Fast-Growing Suburb for New Store Jan. 20 AQ
DR Horton : 2022 & 2023 EEO-1 Disclosure Dec. 19 PU
D.R. Horton, Inc. to Release 2025 First Quarter Earnings on January 21, 2025 Dec. 03 BU
DR Horton : Q4 FY 2024 Earnings Call Transcript 24-10-30 PU
DR Horton : Amendment to Initial Statement of Beneficial Ownership - Form 3/A 24-10-30 PU
More press releases

News in other languages: DR Horton

Question bête : pourquoi les promoteurs US ont baissé depuis que la Fed a commencé à réduire ses taux ? 03:36am
Trump envoie ses premiers scuds 03:02am
En direct des marchés : ça bouge chez Renault et Eramet, fiançailles pour Generali et Natixis, Orsted souffre 02:53am
DR Horton : en chute après ses trimestriels 24-10-29
Wall Street compte les points présidentiels en attendant Alphabet 24-10-29
More news

Quotes and Performance

1 day+0.72%
1 week+6.68%
Current month+5.60%
1 month+5.76%
3 months-24.11%
6 months-15.07%
Current year+5.60%
More quotes

Course Extremes

1 week
143.29
Extreme 143.29
149.95
1 month
136.23
Extreme 136.23
149.95
Current year
136.23
Extreme 136.23
149.95
1 year
133.02
Extreme 133.02
199.85
3 years
59.25
Extreme 59.25
199.85
5 years
25.51
Extreme 25.51
199.85
10 years
22.97
Extreme 22.97
199.85
More quotes

Managers and Directors: DR Horton

Director TitleAgeSince
Paul Romanowski CEO
 Chief Executive Officer 55 2023-09-30
Bill Wheat DFI
 Director of Finance/CFO 59 2002-12-31
Michael Murray COO
 Chief Operating Officer 59 2014-10-02
Manager TitleAgeSince
Michael Buchanan BRD
 Director/Board Member 78 2003-10-31
Bradley Anderson BRD
 Director/Board Member 64 1998-03-31
David Auld CHM
 Chairman 69 2024-05-16
More insiders

ETFs: DR Horton

Name Weight AuM 1st Jan change Investor Rating
MERLYN.AI BULL-RIDER BEAR-FIGHTER ETF - USD ETF Merlyn.AI Bull-Rider Bear-Fighter ETF - USD
3.30% 0 M€ -1.62% -
SIREN DIVCON DIVIDEND DEFENDER ETF - USD ETF Siren DIVCON Dividend Defender ETF - USD
2.07% 9 M€ +0.94%
JPMORGAN SOCIAL ADVANCEMENT ETF - USD ETF JPMorgan Social Advancement ETF - USD
1.77% 0 M€ +15.09% -
STERLING CAPITAL DIVERSE MULTI-MANAGER ACTIVE ETF- USD ETF Sterling Capital Diverse Multi-Manager Active ETF- USD
1.33% 0 M€ +0.06% -
More ETFs: DR Horton

Other Homebuilding

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
DR HORTON Stock DR Horton
+0.72%+6.68%-4.93%+67.10%47.37B
PULTEGROUP, INC. Stock PulteGroup, Inc.
+0.09%+7.38%+10.33%+123.47%24B
DAIWA HOUSE INDUSTRY CO., LTD. Stock Daiwa House Industry Co., Ltd.
+1.20%+0.45%+1.99%+41.70%18.89B
SEKISUI HOUSE, LTD. Stock Sekisui House, Ltd.
+0.95%+0.89%+3.93%+56.09%14.94B
TOLL BROTHERS, INC. Stock Toll Brothers, Inc.
+0.63%+7.14%+33.70%+131.12%13.52B
BARRATT REDROW PLC Stock Barratt Redrow plc
-0.48%+6.55%-20.43%-36.36%7.65B
SUMITOMO FORESTRY CO., LTD. Stock Sumitomo Forestry Co., Ltd.
+3.43%+7.21%+18.80%+169.60%6.93B
TAYLOR MORRISON HOME CORPORATION Stock Taylor Morrison Home Corporation
-1.07%+7.20%+21.59%+120.59%6.8B
SEKISUI CHEMICAL CO., LTD. Stock Sekisui Chemical Co., Ltd.
+0.47%-1.68%+11.65%+29.59%6.58B
TAYLOR WIMPEY PLC Stock Taylor Wimpey plc
-0.71%+5.32%-21.68%-26.65%5.04B
Average +0.52%+5.70%+5.50%+67.63% 15.17B
Weighted average by Cap. +0.62%+6.14%+4.32%+74.60%
See all sector performances

Financials

2025 *2026 *
Net sales 37.09B 35.66B 33.67B 30.15B 53.1B 3,197B 59.22B 409B 152B 1,319B 139B 136B 5,773B 39.72B 38.2B 36.06B 32.3B 56.88B 3,425B 63.43B 438B 162B 1,413B 149B 146B 6,184B
Net income 4.44B 4.27B 4.03B 3.61B 6.36B 383B 7.1B 49.01B 18.16B 158B 16.66B 16.32B 692B 4.87B 4.68B 4.42B 3.96B 6.97B 420B 7.78B 53.72B 19.91B 173B 18.27B 17.89B 758B
Net Debt 1.42B 1.36B 1.29B 1.15B 2.03B 122B 2.26B 15.61B 5.79B 50.35B 5.31B 5.2B 220B 1.53B 1.47B 1.39B 1.24B 2.19B 132B 2.44B 16.85B 6.25B 54.35B 5.73B 5.61B 238B
More financial data * Estimated data

Company Profile

Logo DR Horton
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (93.3%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (4.4%); - supply of financial services (2.3%).
Employees
14,766
Sector
Homebuilding
Calendar
06:30am - Q1 2025 Earnings Release
More about the company

Quotes

Date Price Change Volume
25-01-17 147.65 $ +0.72% 3,861,325
25-01-16 146.60 $ +0.82% 3,468,031
25-01-15 145.41 $ +1.57% 4,397,826
25-01-14 143.16 $ +3.44% 3,405,421

Delayed Quote Nyse, January 17, 2025 at 04:00 pm EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart DR-HORTON More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
A
surperformance-ratings-light-chart DR-HORTONMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
147.65USD
Average target price
173.85USD
Spread / Average Target
+17.75%
Consensus
Profit revisions
estimates-change-chart DR-HORTON Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart DR-HORTON Company calendar
  1. Stock Market
  2. Equities
  3. DHI Stock